Lungs News and Research

RSS

Speaking releases much more SARS-CoV-2 virus than breathing does

In a recent study published in the journal PNAS, researchers at the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) monitored the airborne mass of speech-generated aerosols using an alternative experimental approach that addressed issues arising from nucleated condensation.

22 Jun 2022

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

E-cigarettes have become increasingly popular among adolescents, and the latest available scientific evidence suggests the use of these products has adverse health effects that may accrue over time, leading to an increased risk of cardiovascular and pulmonary disease over the course of the life of people who use e-cigarettes, according to a new scientific statement from the American Heart Association published today in the Association's peer-reviewed journal, Circulation: Research.

21 Jun 2022

Scientists discover a direct pathway for transport of inhaled fine particles from lungs to the brain

Breathing in polluted air could lead to toxic particles being transported from lungs to brain, via the bloodstream – potentially contributing to brain disorders and neurological damage, a new study reveals.

20 Jun 2022

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Researchers assessed the characteristics of the brain fog reported by some COVID-19 patients.

17 Jun 2022

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

In a recent study posted to the bioRxiv* pre-print server, researchers at Cornell University College of Veterinary Medicine and the University of Illinois Urbana-Champaign compared the infection dynamics, pathogenicity, and tissue tropism of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in adult cats.

17 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

A new study explores the role of non-structural protein 1 (NSP1) in SARS-CoV-2 infection and pathogenesis.

16 Jun 2022

Multiomics identifies genomic risk factors for COVID-19

In a recent Cell Systems study, researchers utilized the RefMap machine learning algorithm to correlate known genomic variations for severe COVID-19 obtained from large-scale genome-wide association studies (GWAS) with single-cell multiome profiling of human lungs.

16 Jun 2022

Stanford researcher outlines pollution and climate change threats to children's health

Horror stories of children trapped in hot cars make headlines, but air pollution and impacts from a changing climate are more constant threats.

15 Jun 2022

Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

15 Jun 2022

UIC scientists identify a dynamic duo of cells in lung blood vessels

Scientists at the University of Illinois Chicago have analyzed gene expression data from more than 35,000 blood vessel cells from the lungs of mice and identified two subtypes.

14 Jun 2022

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

Determining how SARS-CoV-2, the virus causing COVID-19, moves from an early stage of infection, when patients are largely asymptomatic, into a later stage when people may experience life-threatening inflammation in the lungs, is a critical step in understanding how to target and treat the disease more efficiently.

14 Jun 2022

Even mild respiratory COVID can affect the brain

In a recent study published in the journal Cell, researchers explored neurological symptoms and subsequent cognitive impairment experienced by survivors of mild respiratory coronavirus disease 2019 (COVID-19).

14 Jun 2022

Molecular snapshots of the productive infectious entry pathway of SARS-CoV-2 into cells

In a recent study posted to the bioRxiv* pre-print server, researchers in the United States demonstrated that the acidic milieu of the nasal cavity is critical for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tropism.

14 Jun 2022

MIT researchers design new sensor to distinguish between viral and bacterial pneumonia

Many different types of bacteria and viruses can cause pneumonia, but there is no easy way to determine which microbe is causing a particular patient's illness.

13 Jun 2022

WTC responders with chronic conditions appear to have severe Covid-19 and long-term sequelae

A study of 1,280 patients treated and monitored at the Stony Brook World Trade Center Health and Wellness Program who also contracted Covid-19 reveals that the responders who have suffered from chronic conditions from WTC exposures and the experience of the 911 tragedy appear to have more infection severity and long-term sequelae than responders who do not have chronic diseases resulting from WTC exposures.

13 Jun 2022

Lungs News and Research

Speaking releases much more SARS-CoV-2 virus than breathing does

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

Scientists discover a direct pathway for transport of inhaled fine particles from lungs to the brain

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

GPR183 gene a novel drug target for severe COVID-19

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

Multiomics identifies genomic risk factors for COVID-19

Stanford researcher outlines pollution and climate change threats to children's health

Fc-effector functions for selecting COVID-19 convalescent plasma

UIC scientists identify a dynamic duo of cells in lung blood vessels

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

Even mild respiratory COVID can affect the brain

Molecular snapshots of the productive infectious entry pathway of SARS-CoV-2 into cells

MIT researchers design new sensor to distinguish between viral and bacterial pneumonia

WTC responders with chronic conditions appear to have severe Covid-19 and long-term sequelae

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

Inhaled vaccines provide better protection and stronger immunity than nasal sprays, study confirms

A comparison of SARS-CoV-2 and influenza cytokine storms

Study links SARS-CoV-2 specific T cells with inflammation and reduced lung function in long COVID

The ultimate guide to lung research tools and protocols eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News